Answers are grounded in this paper and cite their sources.
Patient and caregiver treatment preferences should be incorporated into the drug development process. We updated a 2018 survey to reflect current knowledge about gene therapy for Duchenne muscular dystrophy (DMD) and obtained new data in the U.S., U.K., and other countries. At data collection in 2023, there were no approved gene therapies for DMD. Using the threshold technique, we assessed the maximum acceptable risk of death (MAR) from non-curative gene therapy with time-limited benefit at different stages of DMD progression. Among 263 participants, mean MAR ranged from 2.4% (treatment in newborns) to 5.4% (last year able to lift hands to mouth); risk tolerance increased with advancing disease stages. Significant proportions (22.4% to 32.8%) were willing to accept MAR >10%. Reasons for higher MAR included the progressive and severe disease, limited treatment alternatives, and participant-reported expected therapy benefits. Those who demonstrated less risk tolerance described uncertainty, maintaining quality of life, optimism regarding future therapies, and the currently uncertain duration of benefit. There were no significant differences in MAR between caregivers and adults with DMD and between respondents in the U.S. and U.K except in the newborn period, though our small sample size is a limitation. MARs remained relatively stable from 2018 to 2023. • Patient preferences should be incorporated into the drug development process. • In 2023, we assessed maximum acceptable risk (MAR) of death from non-curative gene therapy among caregivers and adults with DMD. • MAR increased with disease progression, with highest MAR at 5.4% in the last year of being able to lift one’s hand to one’s mouth (indicating ability to meaningfully use one’s arms). • MAR of death has remained relatively stable from our initial study in 2018 to these 2023 data. • Risk tolerance is similar in US and UK, and patient and caregivers.
No takes yet. Share an insight, caveat, or question.
Peay et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: